Total Payments
$270.43
2021 Payments
$30.40
Companies
3
Transactions
17
Medicare Patients
2,986
Medicare Billing
$133,136
Payment Breakdown by Category
Food & Beverage$270.43 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $270.43 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $183.89 | 15 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.60 | 1 | $0 (2019) |
| Mission Pharmacal Company | $10.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $30.40 | 2 | Genentech USA, Inc. ($30.40) |
| 2020 | $117.76 | 11 | Genentech USA, Inc. ($117.76) |
| 2019 | $111.33 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($75.60) |
| 2017 | $10.94 | 1 | Mission Pharmacal Company ($10.94) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/03/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Virology & Specialty Care | ||||||
| 01/15/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Virology & Specialty Care | ||||||
| 12/22/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Virology & Specialty Care | ||||||
| 12/22/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: Virology & Specialty Care | ||||||
| 12/18/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Virology & Specialty Care | ||||||
| 12/18/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: Virology & Specialty Care | ||||||
| 12/04/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Virology & Specialty Care | ||||||
| 11/24/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Virology & Specialty Care | ||||||
| 11/18/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Virology & Specialty Care | ||||||
| 11/10/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Virology & Specialty Care | ||||||
| 02/11/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Virology & Specialty Care | ||||||
| 01/31/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Virology & Specialty Care | ||||||
| 01/10/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Virology & Specialty Care | ||||||
| 11/21/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Virology & Specialty Care | ||||||
| 03/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $75.60 | General |
| Category: DIABETES | ||||||
| 02/12/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Virology & Specialty Care | ||||||
| 03/01/2017 | Mission Pharmacal Company | Hycofenix (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Oral antitussive, nasal decongestant and expectorant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 573 | 1,045 | $60,871 | $22,491 |
| 2022 | 16 | 787 | 1,281 | $79,772 | $36,904 |
| 2021 | 17 | 889 | 1,394 | $89,408 | $47,624 |
| 2020 | 15 | 737 | 1,178 | $67,677 | $26,116 |
Total Patients
2,986
Total Services
4,898
Medicare Billing
$133,136
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 72 | $14,544 | $5,821 | 40.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 82 | 87 | $9,788 | $4,374 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 75 | $10,714 | $3,851 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,694 | $3,390 | 35.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 54 | 109 | $3,949 | $1,768 | 44.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,133 | $1,301 | 41.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 74 | 116 | $3,291 | $972.28 | 29.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 19 | 19 | $1,026 | $435.78 | 42.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 19 | 19 | $475.00 | $307.80 | 64.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 14 | $434.00 | $93.10 | 21.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 23 | $115.00 | $78.43 | 68.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 43 | 178 | $3,560 | $54.00 | 1.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 64 | $64.00 | $26.51 | 41.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 47 | 214 | $85.60 | $16.87 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 177 | $18,526 | $11,625 | 62.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 145 | 156 | $23,327 | $7,850 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 61 | $10,746 | $5,100 | 47.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $7,220 | $4,464 | 61.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,050 | $1,990 | 49.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 40 | 43 | $2,638 | $1,974 | 74.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 49 | 104 | $2,656 | $1,690 | 63.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 86 | 117 | $3,181 | $986.64 | 31.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 29 | 31 | $2,320 | $657.87 | 28.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 16 | 16 | $508.00 | $260.35 | 51.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 11 | 11 | $252.00 | $84.51 | 33.5% |
About Dr. John Tinglin, MD
Dr. John Tinglin, MD is a Specialist healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033130760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tinglin, MD has received a total of $270.43 in payments from pharmaceutical and medical device companies, with $30.40 received in 2021. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($270.43).
As a Medicare-enrolled provider, Tinglin has provided services to 2,986 Medicare beneficiaries, totaling 4,898 services with total Medicare billing of $133,136. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Montgomery, AL
- Active Since 07/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1033130760
Products in Payments
- Xofluza (Drug) $183.89
- JARDIANCE (Drug) $75.60
- Hycofenix (Drug) $10.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Montgomery
Dr. Rosa Bell, Md, MD
Specialist — Payments: $20,679
Specialist $20,679
Dr. John Robertson, M.d, M.D
Specialist — Payments: $15,644
Specialist $15,644
Dr. Stephen Owens, M.d, M.D
Specialist — Payments: $10,634
Specialist $10,634
Dr. Patrick Budny, M.d, M.D
Specialist — Payments: $8,612
Specialist $8,612
Dr. Michael Bentley, M.d, M.D
Specialist — Payments: $7,374
Specialist $7,374
Rafael Lopez, M.d, M.D
Specialist — Payments: $5,281
Specialist $5,281